<DOC>
	<DOCNO>NCT00707044</DOCNO>
	<brief_summary>Objective : To evaluate safety cost-effectiveness Short Stay Intensive Care ( SSIC ) treatment low-risk coronary artery bypass patient Design : Randomized clinical equivalence trial Setting : University Hospital Maastricht , Netherlands Patients : low-risk coronary artery bypass patient Interventions : 600 patient randomly assign undergo either SSIC treatment ( 8 hour Intensive Care ) control treatment ( care usual , overnight Intensive Care ) . Measurements : The primary outcome measure Intensive Care ( IC ) readmission total hospital stay . The secondary outcome measure total hospital cost , Quality Life ( QoL ) , postoperative morbidity mortality . Hospital cost consist cost hospital admission ( ) outpatient cost .</brief_summary>
	<brief_title>Short-Stay Intensive Care Coronary Artery Bypass Patients</brief_title>
	<detailed_description />
	<criteria>Coronary artery bypass patient age old 78 year , ejection fraction le 30 % stage 3 obesity ( BMI &gt; 40kg/m2 ) haemodialysis ( kidney replace therapy ) pulmonary hypertension ( systolic &lt; 40mmHg ) recent CVA ( &lt; 1month ) recent myocardial infarction ( &lt; 24hours ) cardiogenic shock , ( systolic blood pressure &lt; 80mmHg , central filling pressure &gt; 20mmHg , cardiac index &lt; 1.8 litres/minute/m2 ) , need inotropic therapy ( &gt; 5mg/mcg/min . dopamine dobutamine ) ongoing infarction ( significant increase enzyme `` CKMB '' within 4 hour surgery ) need intraaortic balloon pump inability give inform consent inability speak/ read/ understand Dutch language patient emergency surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>